BWA
TEVA icon

BDO Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

BDO Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$7.53K Hold
1,000
– – ﹤0.01% 736
2023
Q1 		$8.85K Hold
1,000
– – ﹤0.01% 723
2022
Q4 		$9.12K Hold
1,000
– – ﹤0.01% 698
2022
Q3 		$8K Hold
1,000
– – ﹤0.01% 761
2022
Q2 		$8K Hold
1,000
– – ﹤0.01% 724
2022
Q1 		$9K Hold
1,000
– – ﹤0.01% 756
2021
Q4 		$8K Buy
+1,000
New +$9.03K ﹤0.01% 768
2020
Q3 		– Sell
-10
Closed – – 948
2020
Q2 		$0 Hold
10
– – ﹤0.01% 767
2020
Q1 		$0 Buy
+10
New +$102 ﹤0.01% 825
2018
Q4 		– Sell
-391
Closed -$8K – 623
2018
Q3 		$8K Sell
391
-710
-64% -$16.5K ﹤0.01% 479
2018
Q2 		$27K Buy
1,101
+1,000
+990% +$20.4K 0.01% 357
2018
Q1 		$2K Sell
101
-101
-50% -$1.97K ﹤0.01% 525
2017
Q4 		$4K Buy
202
+1
+0.5% +$15 ﹤0.01% 393
2017
Q3 		$4K Sell
201
-276
-58% -$6.21K ﹤0.01% 360
2017
Q2 		$16K Buy
+477
New +$14.8K 0.01% 325

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BDO Wealth Advisors's TEVA Position: Q2 2023 in Review

BDO Wealth Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2023 at 1,000 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

BDO Wealth Advisors first reported a position in TEVA in Q2 2017 and has held it in 15 quarters since. The position peaked at $27K in Q2 2018. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • BDO Wealth Advisors held 1,000 shares of Teva Pharmaceuticals worth $7.53K as of Q2 2023.
  • BDO Wealth Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2023.
  • Teva Pharmaceuticals made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #736 holding.
  • BDO Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2017 and has held it in 15 quarters since.
  • BDO Wealth Advisors's Teva Pharmaceuticals position peaked at $27K in Q2 2018.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.